Tutorials
TSX:GUD (Canada)  
Knight Therapeutics Inc logo

Knight Therapeutics Inc

C$ 5.66 (-1.05%) Aug 9
P/E:
At Loss
P/B:
0.80
Market Cap:
C$ 648.77M ($ 503.21M)
Enterprise V:
C$ 525.16M ($ 407.34M)
Volume:
57.38K
Avg Vol (2M):
123.38K
Also Trade In:
Volume:
57.38K
Market Cap C$:
648.77M
Market Cap $:
503.21M
PE Ratio:
At Loss
Avg Vol (2-Month):
123.38K
Enterprise Value C$:
525.16M
Enterprise Value $:
407.34M
PB Ratio:
0.80
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Knight Therapeutics Inc
NAICS : 325412 SIC : 3741
3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8
Description
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Name Current Vs Industry Vs History
Cash-To-Debt 3.64
Equity-to-Asset 0.83
Debt-to-Equity 0.06
Debt-to-EBITDA 1.22
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.05
Distress
Grey
Safe
Beneish M-Score -2.34
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 53.98
9-Day RSI 54.9
14-Day RSI 55.43
6-1 Month Momentum % -2.17
12-1 Month Momentum % 2.85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.73
Quick Ratio 2.1
Cash Ratio 1.4
Days Inventory 182.51
Days Sales Outstanding 87.6
Days Payable 180.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 6.2

Financials

TSX:GUD's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 261.216
EPS (TTM) (C$) -0.06
Beta 0.5
Volatility % 13.23
14-Day RSI 55.43
14-Day ATR (C$) 0.128438
20-Day SMA (C$) 5.5955
12-1 Month Momentum % 2.85
52-Week Range (C$) 5.03 - 5.85
Shares Outstanding (Mil) 114.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Knight Therapeutics Inc Filings

Document Form Filing Date
No Filing Data